Archive

20 Mar 2017

Study reveals possible drug targets for cancers with a faulty PTEN gene

Cooperating genes and pathways found for tumour suppressor gene PTEN. These are possible drug targets for cancers with a faulty PTEN gene.

13 Mar 2017

Study shows that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes

Researchers from the Wellcome Trust Sanger Institute and their collaborators have discovered that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes. The results published today (13 March) in Nature Medicine open up the possibility of up to 20 per cent of women being treated with PARP inhibitors, a class of drug previously only thought to be effective for women with an inherited BRCA1 or BRCA2 mutation.

8 Mar 2017

Eleftheria Zeggini of the Wellcome Trust Sanger Institute and Helen Parkinson of the European Bioinformatics Institute (EMBL-EBI) have been recognised for their work in promoting gender equality on the Wellcome Genome Campus

Two staff members were recognised by Mike Stratton, Ewan Birney and Rolf Apweiler today, International Women’s Day (8 March) for their efforts in supporting women in science, in the third annual Wellcome Genome Campus Best Practice Award.

7 Mar 2017

Dr Matt Hurles, leader of the DDD Programme and co-founder of Institute spin-out Congenica, has been confirmed as the new Head of the Human Genetics Programme

On Tuesday 7 March Dr Matt Hurles accepted the permanent position of Head of the Human Genetics Programme. Dr Hurles joined the Sanger Institute in 2003 as a member of Faculty to pursue his interest in understanding the genetic causes underlying severe developmental disorders, and understanding how DNA mutations arise as it is passed from generation to generation.

3 Mar 2017

Scientists reveal how mouse T cells develop

Scientists have revealed for the first time how immature mouse immune cells, called T cells, choose which type of skills they will develop to fight malaria infection. Reported in Science Immunology, researchers tracked individual T cells during infection with malaria parasites. They discovered a whole network of chemical conversations between different types of cells that influenced T cell specialisation.  

27 Feb 2017

Congenica raises £8M ($10M) to drive international expansion of its genome analysis business

20 Feb 2017

The Institute for Systems Biology has embedded the COSMIC data within their Cancer Genomics Cloud (CGC), which is a cloud-based platform that uses Google BigQuery technology to bring unprecedented computing power to researchers around the world

The Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC) team announces a new agreement to provide their data to the U.S.-based Institute for Systems Biology (ISB).

10 Feb 2017

Professor Sir Mike Stratton will lead an international team to help transform our understanding of what causes cancer

The first Cancer Research UK Grand Challenge Project seeks to fill in the missing gaps to identify unknown cancer-causing factors and reveal how they lead to cancer. To do this 5,000 pancreatic, kidney, oesophageal and bowel cancer patients, from five continents will be studied and compared.

10 Feb 2017

This could help develop a more effective malaria vaccine

Researchers discover how a promising malarial vaccine target - the protein RH5 - uses a previously mysterious protein P113 to create a bridge between the parasite and red blood cell.

6 Feb 2017

The ability of malaria parasites to persist in the body for years is linked to the expression of a set of genes from the pir gene family

Mouse study shows that as few as 1 in 10 of the parasites that initially appear in the blood express this set of pir genes. But almost all the parasites found persisting in the body at later times express the genes. If the biological mechanisms involved can be targeted, long-lasting persistent malaria infection could be prevented, and prevent ongoing transmission.

Pages